4-(2-hydroxy-3-(N-isopropylamino)propoxyimino)carane: structure given in first source; RN given refers to the (1R-(1alpha,3E(R*),4beta,6alpha))-isomer
ID Source | ID |
---|---|
PubMed CID | 9576915 |
MeSH ID | M0212292 |
Synonym |
---|
bicyclo(4.1.0)heptan-3-one, 4,7,7-trimethyl-, o-(2-hydroxy-3-((1-methylethyl)amino)propyl)oxime, (1r-(1alpha,3e(r*),4beta,6alpha))- |
4-(2-hydroxy-3-(n-isopropylamino)propoxyimino)carane |
145841-19-6 |
hipi-cis-carane |
1-(propan-2-ylamino)-3-[(e)-[(1r,4r,6s)-4,7,7-trimethyl-3-bicyclo[4.1.0]heptanylidene]amino]oxypropan-2-ol |
1-(propan-2-ylamino)-3-[(4,7,7-trimethyl-3-bicyclo[4.1.0]heptanylidene)amino]oxypropan-2-ol |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |